Growth Metrics

Cytosorbents (CTSO) Cash & Equivalents Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.15%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 24.05%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -7.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 100.41%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -22.13%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 20.15%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 23.57%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -7.71%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 156.03%
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn -63.39%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -63.39%
Dec 31, 2025 -36.00%
Sep 30, 2025 15.94%
Jun 30, 2025 56.98%
Mar 31, 2025 52.29%
Dec 31, 2024 -30.90%
Sep 30, 2024 -22.62%
Jun 30, 2024 -50.76%
Mar 31, 2024 -54.81%
Dec 31, 2023 -36.19%
Sep 30, 2023 -62.75%
Jun 30, 2023 -56.24%
Mar 31, 2023 -55.72%
Dec 31, 2022 -57.53%
Sep 30, 2022 -63.06%
Jun 30, 2022 -54.02%
Mar 31, 2022 -37.16%
Dec 31, 2021 -27.00%
Sep 30, 2021 -30.62%
Jun 30, 2021 86.85%
Mar 31, 2021 159.46%
Dec 31, 2020 483.87%
Sep 30, 2020 450.62%
Jun 30, 2020 114.87%
Mar 31, 2020 34.31%
Dec 31, 2019 -45.31%
Sep 30, 2019 -35.86%
Jun 30, 2019 -35.36%
Mar 31, 2019 -6.84%
Dec 31, 2018 29.14%
Sep 30, 2018 61.76%
Jun 30, 2018 54.14%
Mar 31, 2018 550.92%
Dec 31, 2017 230.24%
Sep 30, 2017 141.57%
Jun 30, 2017 89.18%
Mar 31, 2017 -8.41%
Dec 31, 2016 -1.35%
Sep 30, 2016 -13.68%
Jun 30, 2016 8.15%
Mar 31, 2016 -66.05%
Dec 31, 2015 47.47%
Sep 30, 2015 1,604.01%
Jun 30, 2015 64.34%
Mar 31, 2015 62.38%
Dec 31, 2014 65.15%
Sep 30, 2014 -81.56%
Jun 30, 2014 160.79%
Mar 31, 2014 369.94%
Dec 31, 2013 26.23%
Sep 30, 2013 14.01%
Jun 30, 2013 7.39%
Mar 31, 2013 -24.28%
Dec 31, 2012 45.73%
Sep 30, 2012 -10.24%
Jun 30, 2012 -49.02%
Mar 31, 2012 -26.00%
Dec 31, 2011 12.41%
Sep 30, 2011 202.83%
Jun 30, 2011 473.70%